Document Detail


Effect of vitamin E therapy on oxidative stress and erythrocyte osmotic fragility in patients on peritoneal dialysis and hemodialysis.
MedLine Citation:
PMID:  17173246     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Several medications have been tested with the aim of decreasing oxidative stress and erythrocyte osmotic fragility in patients on dialysis. The aim of the present study was to assess the influence of vitamin E therapy on oxidative stress and erythrocyte osmotic fragility in patients on hemodialysis (HD) and peritoneal dialysis (PD). METHODS: This was a placebo-controlled study. The study was performed on 34 HD patients, 13 PD patients and 22 healthy volunteers with a mean age of 45.57 +/- 8.54 years. HD patients were divided into 2 groups: treatment (n=19) and control (n=15). Vitamin E was administered, 300 mg/day, to the HD treatment group and PD patients for 20 weeks. Lipid peroxidation, antioxidant condition and erythrocyte osmotic fragility (EOF) were examined before and after treatment. RESULTS: Before the treatment, the levels of EOF (p<0.001) and malondialdehyde (MDA) (p<0.001) were significantly lower, and erythrocyte superoxide dismutase (SOD) (p=0.001) and vitamin E levels (p<0.001) were significantly higher in the healthy group than PD and HD groups. Serum vitamin E increased from 0.93 +/- 0.16 to 1.09 +/- 0.14 mg/dL (p=0.001), EOF decreased from 0.49% +/- 0.03% to 0.42% +/- 0.04% NaCl (p<0.001), and plasma MDA values decreased from 2.77 +/- 0.87 to 2.20 +/- 0.767 nmol/mL (p=0.018) in the HD treatment group after vitamin E treatment. Levels of EOF decreased from 0.51% +/- 0.09% to 0.43% +/- 0.03% NaCl in the PD treatment group after vitamin E treatment (p=0.021). CONCLUSION: Vitamin E therapy is effective in decreasing the levels of EOF in patients on HD and PD, and it is also effective in decreasing lipid peroxidation in patients on HD.
Authors:
Atilla Uzum; Omer Toprak; M Koray Gumustas; Sentrurk Ciftci; Saniye Sen
Related Documents :
131236 - Clonazepam in the treatment of choreiform activity.
16046506 - Effectiveness of a multidisciplinary kidney disease clinic in achieving treatment guide...
16686316 - Using the ratio of serum osteoprotegerin ligand to osteoprotegerin to evaluate renal os...
16797276 - Complications of arteriovenous fistula in dialysis patients.
20607336 - Seizure after intrathecal baclofen bolus in a multiple sclerosis patient treated with o...
8778256 - Symptomatic and essential palatal tremor. 3. abnormal motor learning.
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  Journal of nephrology     Volume:  19     ISSN:  1121-8428     ISO Abbreviation:  J. Nephrol.     Publication Date:    2006 Nov-Dec
Date Detail:
Created Date:  2006-12-18     Completed Date:  2007-04-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9012268     Medline TA:  J Nephrol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  739-45     Citation Subset:  IM    
Affiliation:
Department of Nephrology, Ataturk Training and Research Hospital, Izmir, Turkey. info@omertoprak.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antioxidants / administration & dosage*,  pharmacokinetics
Female
Humans
Lipid Peroxidation / drug effects
Male
Malondialdehyde / blood
Middle Aged
Osmotic Fragility / drug effects
Oxidative Stress / drug effects*
Prospective Studies
Renal Dialysis*
Vitamin E / administration & dosage*,  pharmacokinetics
Chemical
Reg. No./Substance:
0/Antioxidants; 1406-18-4/Vitamin E; 542-78-9/Malondialdehyde

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.
Next Document:  Terminal complement complexes in childhood type I membranoproliferative glomerulonephritis.